Thomas Errath

Thomas Errath possesses extensive experience in financial planning and analysis, holding positions such as Associate Director, FP&A at both Dragonfly Therapeutics, Inc. and AlloVir. Prior to this, Thomas served as Senior Manager, FP&A and Manager, Commercial FP&A at Akcea Therapeutics and held the role of Senior Financial Analyst at Takeda Oncology. Thomas's career started at Takeda Oncology as a Financial Analyst and earlier as a Financial Analyst Intern, demonstrating a progressive trajectory in the financial sector within the biotech and pharmaceutical industries.